Asylia Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 25, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $14,500,000
Company Info
- Founding Year
- 2019
- Founders
- Robert Orlowski, MD, Ph.D., Ronald A. DePinho, MD, Richard J. Jones, Ph.D.
- Company Description
- Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.
- Market
- Cancer and autoimmune diseases
- Location
- Houston, Texas, United States
- Coinvestors
- poros Bioventures